Literature DB >> 7728768

Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line.

H Baba1, T Urano, K Okada, K Furukawa, E Nakayama, H Tanaka, K Iwasaki, H Shiku.   

Abstract

A series of sublines of a murine melanoma B16 of C57BL/6 origin were established and examined regarding their metastatic capacity and expression of nm23. The number of pulmonary metastases developed by these sublines was inversely correlated with the expression of two isotypes of nm23, nm23-M1 and nm23-M2. The cDNAs of nm23-M1, nm23-M2, and a combination of both were transfected into the highly metastatic melanoma subline FE7, with low nm23 expression. FE7 transfectants of any of these cDNAs expressed transfected genes, and their metastatic capacity was suppressed when compared with parental FE7 or FE7 transfected with a control neo gene. These cell lines, however, did not change in terms of in vitro growth in the presence of 3 or 10% fetal bovine serum and in vivo growth when injected s.c. into C57BL/6-nu/nu mice. Similar experiments were also performed using FE7 transfectants of human nm23 genes. Transfectants of nm23-H1, nm23-H2, and their combination did not present altered metastatic potential. These findings indicated that two murine isotypes of nm23 but not those of humans are intimately related with the suppression of metastasis in the murine body.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728768

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

Review 1.  Regulation of cellular functions by nucleoside diphosphate kinases in mammals.

Authors:  N Kimura; N Shimada; M Fukuda; Y Ishijima; H Miyazaki; A Ishii; Y Takagi; N Ishikawa
Journal:  J Bioenerg Biomembr       Date:  2000-06       Impact factor: 2.945

Review 2.  New insights into Nm23 control of cell adhesion and migration.

Authors:  Henri-Noël Fournier; Corinne Albigès-Rizo; Marc R Block
Journal:  J Bioenerg Biomembr       Date:  2003-02       Impact factor: 2.945

3.  Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity.

Authors:  P D Wagner; P S Steeg; N D Vu
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 4.  Translational approaches using metastasis suppressor genes.

Authors:  Diane Palmieri; Christine E Horak; Jong-Heun Lee; Douglas O Halverson; Patricia S Steeg
Journal:  J Bioenerg Biomembr       Date:  2006-08       Impact factor: 2.945

Review 5.  Understanding h-prune biology in the fight against cancer.

Authors:  Natascia Marino; Massimo Zollo
Journal:  Clin Exp Metastasis       Date:  2007-10-19       Impact factor: 5.150

Review 6.  Clinical-translational approaches to the Nm23-H1 metastasis suppressor.

Authors:  Patricia S Steeg; Christine E Horak; Kathy D Miller
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

7.  Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).

Authors:  M E Miele; A De La Rosa; J H Lee; D J Hicks; J U Dennis; P S Steeg; D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

8.  Tissue disposition of zidovudine and its phosphorylated metabolites in zidovudine-treated healthy and retrovirus infected mice.

Authors:  H H Chow; G Brookshier; P Li
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

9.  The metastatic suppressor Nm23-H1 interacts with EBNA3C at sequences located between the glutamine- and proline-rich domains and can cooperate in activation of transcription.

Authors:  Chitra Subramanian; Erle S Robertson
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 10.  Basic and translational advances in cancer metastasis: Nm23.

Authors:  Taoufik Ouatas; Massimiliano Salerno; Diane Palmieri; Patricia S Steeg
Journal:  J Bioenerg Biomembr       Date:  2003-02       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.